Remove Cardiomyopathy Remove Innovation Remove Technology
article thumbnail

Ensight-AI Awarded FDA’s Breakthrough Device Designation for Its ECGVision-TTR Technology for Early Detection of ATTR-Cardiomyopathy

DAIC

Food and Drug Administration’s ( FDA ) Breakthrough Device Designation for their ECGvision-TTR Technology for early detection of ATTR-Cardiomyopathy. Food and Drug Administration’s (FDA) Breakthrough Devices Program , which provides patients with timely access to innovative medical devices.

article thumbnail

Engineered exosomes: a potential therapeutic strategy for septic cardiomyopathy

Frontiers in Cardiovascular Medicine

Septic cardiomyopathy, a life-threatening complication of sepsis, can cause acute heart failure and carry a high mortality risk. Fortunately, engineered exosomes, created through bioengineering technology, may represent a potential new treatment method. Current treatments have limitations.

article thumbnail

The Texas Heart Institute Collaborates on Multi-institutional DOD Grant to Develop Novel Left Ventricular Assist Device

DAIC

million Department of Defense grant awarded to the Georgia Institute of Technology (Georgia Tech), Yaxin Wang, PhD (seated left), O.H. Through a new four-year, $7.8 The research is funded by a four-year, $7.8 The Texas Heart Institute will receive approximately $2.94 million from the award to fund its role in the research effort.

article thumbnail

FDA Clears First AI to Aid Heart Failure Detection During Routine Check-ups

DAIC

This leap in early detection marks both a significant medical innovation and a new era in the detection of cardiovascular disease. Importantly, since a stethoscope is small and portable, this technology can be used in urban and remote locations, and hopefully help address care in underserved areas.” For the first time, U.S. In the U.S.,

article thumbnail

Latest developments in the Cardiac Healthcare system through AI

Wellnest

By harnessing the power of the latest technology, healthcare providers can enhance diagnostics, treatment planning, and patient care. The latest technology utilizes the existing data of an Artificial Neural network (ANN). The deep learning algorithm helps segment the left ventricle predicting cardiomyopathy and ejection fraction.

article thumbnail

Why ICDs are less effective in Non Ischemic DCM ?

Dr. S. Venkatesan MD

Still, Mirowski”s electrical kid survived the test of time and evolved with great technological innovations from companies like Medtronic, Guidant, Abbot etc. 2020) The un-disputable fact is ischemic DCM has a target to treat, though it is termed as cardiomyopathy. ICD explanation epidemic in the past was a true story.

article thumbnail

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

DAIC

12:15 p.m.